메뉴 건너뛰기




Volumn 19, Issue 6, 2017, Pages 800-809

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study

(15)  Teerlink, John R a   Voors, Adriaan A b   Ponikowski, Piotr c   Pang, Peter S d   Greenberg, Barry H e   Filippatos, Gerasimos f   Felker, G Michael g   Davison, Beth A h   Cotter, Gad h   Gimpelewicz, Claudio i   Boer Martins, Leandro i   Wernsing, Margaret i   Hua, Tsushung A i   Severin, Thomas i   Metra, Marco j  


Author keywords

Acute heart failure; Mortality; Phase 3 trial; Serelaxin; Worsening heart failure

Indexed keywords

PLACEBO; SERELAXIN; RECOMBINANT PROTEIN; RELAXIN; SERELAXIN PROTEIN, HUMAN;

EID: 85018995389     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.830     Document Type: Article
Times cited : (102)

References (42)
  • 18
    • 84959020583 scopus 로고    scopus 로고
    • Serelaxin and acute heart failure
    • Tietjens J, Teerlink JR. Serelaxin and acute heart failure. Heart 2016;102:95–99.
    • (2016) Heart , vol.102 , pp. 95-99
    • Tietjens, J.1    Teerlink, J.R.2
  • 22
    • 60749089513 scopus 로고    scopus 로고
    • A graphical approach to sequentially rejective multiple test procedures
    • Bretz F, Maurer W, Brannath W, Posch M. A graphical approach to sequentially rejective multiple test procedures. Stat Med 2009;28:586–604.
    • (2009) Stat Med , vol.28 , pp. 586-604
    • Bretz, F.1    Maurer, W.2    Brannath, W.3    Posch, M.4
  • 23
  • 26
    • 84872002780 scopus 로고    scopus 로고
    • Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure
    • Erdmann E, Semigran MJ, Nieminen MS, Gheorghiade M, Agrawal R, Mitrovic V, Mebazaa A. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. Eur Heart J 2013;34:57–67.
    • (2013) Eur Heart J , vol.34 , pp. 57-67
    • Erdmann, E.1    Semigran, M.J.2    Nieminen, M.S.3    Gheorghiade, M.4    Agrawal, R.5    Mitrovic, V.6    Mebazaa, A.7
  • 27
    • 33751314230 scopus 로고    scopus 로고
    • ADHERE Study Group. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE
    • 4th
    • Peacock WF 4th, Fonarow GC, Emerman CL, Mills RM, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology 2007;107:44–51.
    • (2007) Cardiology , vol.107 , pp. 44-51
    • Peacock, W.F.1    Fonarow, G.C.2    Emerman, C.L.3    Mills, R.M.4    Wynne, J.5
  • 35
    • 85020578480 scopus 로고    scopus 로고
    • Acute Heart Failure: Diagnosing and Managing Acute Heart Failure in Adults. NICE Clinical Guideline 187, Methods, evidence and recommendations
    • p1–
    • National Clinical Guideline Centre. Acute Heart Failure: Diagnosing and Managing Acute Heart Failure in Adults. NICE Clinical Guideline 187, Methods, evidence and recommendations. London: National Institute for Health and Care Excellence; 2014. p1–329.
    • (2014) London: National Institute for Health and Care Excellence , pp. 329
  • 36
    • 0037181511 scopus 로고    scopus 로고
    • Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial
    • VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531–1540.
    • (2002) JAMA , vol.287 , pp. 1531-1540
    • Investigators, V.M.A.C.1
  • 38
    • 70350077445 scopus 로고    scopus 로고
    • Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure—association with signs and symptoms, hospitalization duration, and 60-day outcomes
    • Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O'Connor CM. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure—association with signs and symptoms, hospitalization duration, and 60-day outcomes. Cardiology 2010;115:29–36.
    • (2010) Cardiology , vol.115 , pp. 29-36
    • Cotter, G.1    Metra, M.2    Weatherley, B.D.3    Dittrich, H.C.4    Massie, B.M.5    Ponikowski, P.6    Bloomfield, D.M.7    O'Connor, C.M.8
  • 40
    • 84939563068 scopus 로고    scopus 로고
    • Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)
    • Kelly JP, Mentz RJ, Hasselblad V, Ezekowitz JA, Armstrong PW, Zannad F, Felker GM, Califf RM, O'Connor CM, Hernandez AF. Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). Am Heart J 2015;170:298–305.
    • (2015) Am Heart J , vol.170 , pp. 298-305
    • Kelly, J.P.1    Mentz, R.J.2    Hasselblad, V.3    Ezekowitz, J.A.4    Armstrong, P.W.5    Zannad, F.6    Felker, G.M.7    Califf, R.M.8    O'Connor, C.M.9    Hernandez, A.F.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.